We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix,  Inc

Download Mobile App




Image: AI-Powered Coronavirus-Screening App (Photo courtesy of NeuTigers)

AI-Powered Coronavirus-Screening App Uses Wearable Biosensors to Detect COVID-19 within Two Minutes

A new AI-powered solution can triage those needing further testing for SARS-CoV-2/COVID-19 using physiological sensors data derived from wearable devices. More...
21 Jan 2021
Image: Innovative Negative Pressure Ventilator (Photo courtesy of Exovent)

Innovative Negative Pressure Ventilator Could Provide Additional Treatment Options for COVID-19 Patients with Respiratory Failure

A new negative pressure ventilator created by a team of anesthetists, nurses and engineers could provide additional treatment options for patients with respiratory failure, including those with COVID-19. More...
21 Jan 2021
Image: Click Tech Single Strain Mutation Mapping Kit for SARS-CoV-2 (Photo courtesy of baseclick GmbH)

New Process Analyzes Predominant SARS-CoV-2 Mutations as Well as Possible New Virus Variants

A new and more efficient process has been developed to determine not only predominant SARS-CoV-2 mutations but also minor occurring mutations in the virus population which might become eventually new strains. More...
21 Jan 2021
Image: BioNTech COVID-19 Vaccine (Photo courtesy of BioNTech)

Pfizer-BioNTech COVID-19 Vaccine Effective Against Highly-Infectious UK Coronavirus Variant, Suggests New Study

Pfizer Inc. (New York, NY, USA) and Biopharmaceutical New Technologies (BioNTech Mainz, Germany) have announced results of a new study which has shown their COVID-19 vaccine elicited antibodies that neutralize the pseudovirus bearing the SARS-CoV-2 UK strain spike protein in cell culture. More...
21 Jan 2021
Image: New Study Provides Encouraging Results on Use of Ivermectin for Reducing Viral Transmission in Patients with Mild COVID-19 (Photo courtesy of Mx. Granger)

New Study Provides Encouraging Results on Use of Ivermectin for Reducing Viral Transmission in Patients with Mild COVID-19

A small pilot study suggests that early administration of ivermectin can reduce viral loads and symptom duration in patients with mild COVID-19, which in turn could help reduce viral transmission. More...
20 Jan 2021
Illustration

Immune Experience with Past Coronavirus Infections Could Affect Disease Outcome in COVID-19 Patients

The results of a new study suggest that the immune systems of people infected with COVID-19 may rely on antibodies created during infections from earlier coronaviruses to help fight the disease that could decide the outcome for patients. More...
20 Jan 2021
Illustration

New Machine Learning Technique Analyzes Electronic Health Records to Predict Mortality in COVID-19 Patients

Researchers have used a machine learning technique called "federated learning" to examine electronic health records to better predict how COVID-19 patients will progress. More...
19 Jan 2021
Copyright © 2000-2021 Globetech Media. All rights reserved.